FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W43716671> ?p ?o ?g. }

• W43716671 endingPage "253" @default.
• W43716671 startingPage "246" @default.
• W43716671 abstract "In recent years, insulin analogues are the benefits of the use in functional intensive insulin therapy for the treatment of diabetes. Shortacting insulin (lispro, aspart and glulisine) and long-acting insulin (glargine and detemir) have been developed for the management of diabetes. Short-acting insulin analogues are an alternative to regular human insulin before meals. These new short-acting insulin analogues show more rapid onset of activity and a shorter duration of action. As a result of these pharmacokinetic differences, an improved postprandial glycemic control is achieved, without increasing the risk of hypoglycemia. In addition, these insulin analogues can be administered immediately before a meal. The long-acting insulin analogues provide basal insulin levels for 24 h when administered once (glargine) or two (detemir) daily. Compared with previous intermediate- or long-acting conventional insulin, these insulins shows a flat profile of plasma insulin levels . The use of these long-acting insulin analogues appears to be associated with a reduced incidence of hypoglycemia, especially at night. The availability of these new insulin analogues has the potential to significantly improve long-term control over blood glucose in diabetic patients. In recent years more and more frequently the method of multiple daily injections (MDI) of insulin is being replaced by the method of continuous subcutaneous insulin infusion (CSII). It is the most physiological way to administer insulin. In recent years treatment with insulin pumps has been used more frequently in the pediatric patients and in the treatment of diabetes in pregnancy. Use of continuous glucose monitoring systems enables detection of glycemia fluctuations unrevealed by selfmonitoring of blood glucose, such as night hypoglycemias and early postprandial hyperglycemias. Real-time systems allow to reduce HbA1c levels and limit number of excursions. Non-invasive glucose measurement devices are introduced. Fully automated continuous glucose monitoring systems integrated with insulin pumps operating in closed-loop model, requiring no patient assistance, are still being researched. Commercially available systems operate in open-loop model, where the patient has to decide on administration and dose of insulin." @default.
• W43716671 created "2016-06-24" @default.
• W43716671 creator A5010943885 @default.
• W43716671 creator A5036285176 @default.
• W43716671 creator A5081008860 @default.
• W43716671 date "2008-05-01" @default.
• W43716671 modified "2023-09-23" @default.
• W43716671 title "New developments in the treatment and monitoring of type 1 diabetes mellitus" @default.
• W43716671 cites W119040087 @default.
• W43716671 cites W1761164047 @default.
• W43716671 cites W1973288625 @default.
• W43716671 cites W1979998887 @default.
• W43716671 cites W1983833796 @default.
• W43716671 cites W1984139024 @default.
• W43716671 cites W1992357136 @default.
• W43716671 cites W1995427842 @default.
• W43716671 cites W1996160128 @default.
• W43716671 cites W2015166879 @default.
• W43716671 cites W2021373511 @default.
• W43716671 cites W2024571159 @default.
• W43716671 cites W2025505804 @default.
• W43716671 cites W2025972201 @default.
• W43716671 cites W2028141306 @default.
• W43716671 cites W2032680655 @default.
• W43716671 cites W2035530611 @default.
• W43716671 cites W2039958848 @default.
• W43716671 cites W2049185335 @default.
• W43716671 cites W2054412998 @default.
• W43716671 cites W2055508765 @default.
• W43716671 cites W2063281481 @default.
• W43716671 cites W2063661786 @default.
• W43716671 cites W2065073881 @default.
• W43716671 cites W2066352131 @default.
• W43716671 cites W2067883140 @default.
• W43716671 cites W2073570027 @default.
• W43716671 cites W2073958052 @default.
• W43716671 cites W2074414391 @default.
• W43716671 cites W2074650842 @default.
• W43716671 cites W2078077635 @default.
• W43716671 cites W2080005958 @default.
• W43716671 cites W2080243591 @default.
• W43716671 cites W2080798409 @default.
• W43716671 cites W2083402819 @default.
• W43716671 cites W2095405229 @default.
• W43716671 cites W2099020006 @default.
• W43716671 cites W2103516801 @default.
• W43716671 cites W2106613355 @default.
• W43716671 cites W2111763343 @default.
• W43716671 cites W2112383812 @default.
• W43716671 cites W2118381229 @default.
• W43716671 cites W2120356903 @default.
• W43716671 cites W2122880201 @default.
• W43716671 cites W2126148866 @default.
• W43716671 cites W2140291063 @default.
• W43716671 cites W2141178768 @default.
• W43716671 cites W2141452626 @default.
• W43716671 cites W2144724140 @default.
• W43716671 cites W2147750301 @default.
• W43716671 cites W2168831138 @default.
• W43716671 cites W2172290764 @default.
• W43716671 cites W2177137510 @default.
• W43716671 cites W2191794704 @default.
• W43716671 cites W24443954 @default.
• W43716671 cites W2602570186 @default.
• W43716671 cites W37391199 @default.
• W43716671 cites W67116143 @default.
• W43716671 cites W2196475452 @default.
• W43716671 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18615401" @default.
• W43716671 hasPublicationYear "2008" @default.
• W43716671 type Work @default.
• W43716671 sameAs 43716671 @default.
• W43716671 citedByCount "5" @default.
• W43716671 countsByYear W437166712023 @default.
• W43716671 crossrefType "journal-article" @default.
• W43716671 hasAuthorship W43716671A5010943885 @default.
• W43716671 hasAuthorship W43716671A5036285176 @default.
• W43716671 hasAuthorship W43716671A5081008860 @default.
• W43716671 hasConcept C126322002 @default.
• W43716671 hasConcept C134018914 @default.
• W43716671 hasConcept C2776486108 @default.
• W43716671 hasConcept C2776664568 @default.
• W43716671 hasConcept C2778024521 @default.
• W43716671 hasConcept C2778199505 @default.
• W43716671 hasConcept C2779306644 @default.
• W43716671 hasConcept C2779908123 @default.
• W43716671 hasConcept C2779920387 @default.
• W43716671 hasConcept C2779946736 @default.
• W43716671 hasConcept C2780473172 @default.
• W43716671 hasConcept C2780668416 @default.
• W43716671 hasConcept C2780677441 @default.
• W43716671 hasConcept C2781232474 @default.
• W43716671 hasConcept C2910068830 @default.
• W43716671 hasConcept C3019948211 @default.
• W43716671 hasConcept C555293320 @default.
• W43716671 hasConcept C71924100 @default.
• W43716671 hasConceptScore W43716671C126322002 @default.
• W43716671 hasConceptScore W43716671C134018914 @default.
• W43716671 hasConceptScore W43716671C2776486108 @default.

• next